| payload |
{"created_at":"2026-04-09T01:43:26.310 {"created_at":"2026-04-09T01:43:26.310695+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:5b30619bbaf165dd","evidence_event_ids":["evt_80747e771160"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUFVFTUFycnJlMTlyeHFMZ1YwU2gtQUlPVjhuWEUtYlYyYURsM1pBUUt0V2xhUWV1Q1djZFd1TnRCcWVqQXdZRUE3RUVZQlFyaXRsSnd1Rk9MMWFRcE9fdmo0Qy15al9oWmViMUVYWnNGdTlJbG9wVWhXQThhUk02UDZYTEo?oc=5","as_of":"2026-04-09T01:43:26.310695+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUFVFTUFycnJlMTlyeHFMZ1YwU2gtQUlPVjhuWEUtYlYyYURsM1pBUUt0V2xhUWV1Q1djZFd1TnRCcWVqQXdZRUE3RUVZQlFyaXRsSnd1Rk9MMWFRcE9fdmo0Qy15al9oWmViMUVYWnNGdTlJbG9wVWhXQThhUk02UDZYTEo?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_4d497b0d2058dd6c","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T01:56:32.799277+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUFVFTUFycnJlMTlyeHFMZ1YwU2gtQUlPVjhuWEUtYlYyYURsM1pBUUt0V2xhUWV1Q1djZFd1TnRCcWVqQXdZRUE3RUVZQlFyaXRsSnd1Rk9MMWFRcE9fdmo0Qy15al9oWmViMUVYWnNGdTlJbG9wVWhXQThhUk02UDZYTEo?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUFVFTUFycnJlMTlyeHFMZ1YwU2gtQUlPVjhuWEUtYlYyYURsM1pBUUt0V2xhUWV1Q1djZFd1TnRCcWVqQXdZRUE3RUVZQlFyaXRsSnd1Rk9MMWFRcE9fdmo0Qy15al9oWmViMUVYWnNGdTlJbG9wVWhXQThhUk02UDZYTEo?oc=5","source_event_id":"evt_80747e771160","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"16f7ec04ba6695e6","kind":"ipo_calendar","published_at":"2026-04-09T01:20:00+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.78,"dates_mentioned":[],"entities":[{"asset_class":"equity (IPO filing)","name":"Avalyn Pharma","relevance":"primary","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["No IPO filing date is provided in the provided text.","No exchange, ticker symbol, offering size, pricing, or underwriters are provided in the provided text.","No details on the IPO prospectus contents or financial/clinical milestones are provided in the provided text.","The provided article text appears to contain only page styling/HTML and does not include the substantive article body beyond the headline/source summary."],"key_facts":["Endpoints News reports that pulmonary fibrosis biotech Avalyn Pharma filed for an IPO."],"numeric_claims":[],"primary_claim":"Avalyn Pharma filed for an IPO.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"Pulmonary fibrosis biotech Avalyn Pharma has filed for an IPO, according to Endpoints News.","topics":["IPO filing","biotechnology","pulmonary fibrosis"]},"source":"Endpoints News","source_domain":"gstatic.com","summary":"Pulmonary fibrosis biotech Avalyn Pharma files for IPO Endpoints News","tickers":[],"title":"Pulmonary fibrosis biotech Avalyn Pharma files for IPO - Endpoints News","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}... |